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Abstract
Background: Cocaine intoxication is found in a significant
subset of emergency department (ED) patients presenting
with traumatic brain injury (TBI). Objectives: To investigate
the effects of acute cocaine intoxication on physiologic and
metabolic parameters in a model of experimental TBI.
Methods: Under inhalational anesthesia, swine were in-
strumented and subjected to fluid percussion TBI of 3 atm.
Two groups were studied: TBI and cocaine (n = 7) and TBI
only (n = 7). Two sequential doses of cocaine hydrochloride
were administered intravenously to the animals receiving
cocaine: 4 mg/kg 10 minutes prior to injury and 2 mg/kg
1 minute prior to injury. Control animals received normal
saline. Cardiorespiratory and cerebral physiologic data were
monitored for 180 minutes following injury. Cerebral blood
flow (CBF) was measured using dye-labeled microspheres.
Serum cocaine levels were measured by gas chromatogra-
phy/mass spectrometry. Results: Mean (6SD) cocaine
levels at the time of injury were 1,771 (6403) ng/mL. All
animals survived the 180-minute observation period. There
was a trend toward higher intracranial pressure (ICP) in
the control (15.4 6 8.2) vs. cocaine-treated (11.1 6 5.8)
animals, although this did not reach statistical significance
(p = 0.18). Cerebral venous lactate (CVL) levels also trended
higher in the control (1.14 6 0.22) vs. cocaine-treated (0.91 6
0.19) groups (p = 0.06). Cerebral perfusion pressures (CPPs),
however, did not differ between groups. The CBF values
decreased significantly from baseline in both groups but
were not different between groups. Conclusions: Cocaine-
intoxicated animals subjected to TBI showed no significant
difference in primary outcome measures of CPP or CBF,
although a nonsignificant trend toward lower ICP was
noted. Overall, acute cocaine intoxication did not adversely
affect the physiologic parameters examined in this TBI
model. Key words: traumatic brain injury; cocaine. ACA-
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Traumatic brain injury (TBI) is a significant societal
problem, with considerable morbidity, mortality, and
monetary costs. The Centers for Disease Control and
Prevention estimate that annually, almost 1.3 million
people sustain a TBI, with 280,000 hospitalizations
and 50,000 deaths.1–4 Most patients who sustain sig-
nificant injuries present to emergency departments
(EDs) for initial stabilization and treatment.
There is clearly an association between trauma and
cocaine abuse/intoxication, as noted in multiple clin-
ical studies.5–7 There is also a significant subset of
patients who present to EDs with TBI and concurrent
cocaine intoxication, although these statistics are not
as well documented. As of 1997, estimates from urban
centers suggest that there are 1.5 million cocaine users
in the United States.8 In 1996, it was estimated that
there were more than 150,000 annual ED presentations
related to cocaine intoxication and cocaine-related in-
cidents, representing a 78% increase from 1990.8
Cocaine has direct effects on the cerebral blood
vessels and neurologic physiology. It is a sympathomi-
metic, and blocks norepinephrine, dopamine, and sero-
tonin reuptake. This results in elevated levels of these
neurotransmitters at the synapse level.9 At higher
doses, it can cause vasospasm, platelet aggregation,
and acute thrombosis, which can result in myocardial
infarction or stroke.9,10 Tachycardia and hypertension
from sympathomimetic stimulation are common.
Cocaine-induced cardiac dysrhythmias are common
as well, and may result from increased myocardial
oxygen demand, acute vasospasm, or sodium channel
blockade.9,11 In TBI, cocaine could either increase car-
diac output secondary to its sympathomimetic effects
or compromise cardiac output in the setting of ventric-
ular arrhythmias or acute vasospasm, with resulting
effects on cerebral blood flow (CBF). In addition, acute
cerebral vasospasm might primarily decrease CBF,
again increasing the potential for secondary brain
injury following the primary event, although, to the
best of our knowledge, these effects have not been
demonstrated in an animal model. With a greater
understanding of the physiologic effects of cocaine in
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this setting, one might be able to better tailor monitor-
ing and resuscitation of cocaine-intoxicated TBI pa-
tients in the ED. For example, if it were known that
cerebral perfusion pressure (CPP) and CBF were lower
in these patients, theoretically resuscitating to higher
mean arterial pressures (MAPs) may be appropriate.
Knowledge of cocaine’s effects could affect choice of
anesthesia and other pharmacotherapy, for similar
reasons. Also, earlier invasive intracranial monitoring
could be considered in cocaine-intoxicated patients if
deleterious effects were demonstrated.
Other sympathomimetic agents have been shown to
improve neurologic recovery in brain-injured animals.
D-amphetamine accelerates recovery of motor func-
tion and visual deficits in rats and cats subjected to
cortical ablation.12–15 This may be in part due to
increased levels of circulating catecholamines.16 Very
few studies have assessed the effects of acute cocaine
intoxication on TBI. Muir et al., using a model of fluid
percussion TBI in rats, demonstrated that animals
pretreated with cocaine experienced lower blood
pressures following injury, although CBF was actually
higher at one hour post-injury.17,18 The cocaine-
intoxicated animals had milder motor deficits follow-
ing injury, but there was no difference in cognitive
function. We know of no published investigations
using large animal models that have studied the effect
of cocaine in TBI on physiologic and cerebrovascular
parameters.
Our study sought to investigate the effects of acute
cocaine intoxication in a large animal model of TBI that
would better replicate human physiology. The hypoth-
esis was that animals subjected to acute cocaine intox-
ication would have lower CPPs, poorer CBFs, and a
decreased cerebral oxygen extraction ratio (CO2ER)
compared with control animals. It was believed that
the sympathomimetic effects of hypertension and in-
creased vascular resistance as well as acute cerebral
vasospasmwould predominate and compromise these
primary outcomes. The aim was to delineate the acute
effects of the drug on these and other important
physiologic and metabolic parameters in the setting
of a significant TBI.
METHODS
Study Design. This was a laboratory investigation
of the effects of cocaine on animals subjected to TBI.
Swine were chosen for this investigation because their
physiologic response to intoxication and TBI simu-
lates the human physiologic response more closely
than any other nonprimate model. Immature swine
have cardiovascular, cerebrovascular, hematologic,
and electrolyte profiles that are almost identical to
those of young humans.19–26 A fluid percussion injury
model was chosen because it has been studied exten-
sively, is highly reproducible, and incorporates sec-
ondary injury.27–35 Ventilation was controlled and
oxygenationmaintained, because this closely simulates
the clinical picture, following management guidelines
for TBI that include early intubation and controlled
ventilation.9 The protocol was reviewed and approved
by the University Committee on Use and Care of
Animals at the University of Michigan, and was in
accordancewith theNational Institute of Health guide-
lines for ethical animal research.
Animal Subjects and Preparation. Immature,mixed-
breed swineof either gender, weighing 18–23 kg, were
fasted the night prior to the experiment but allowed
free access to water. Animals were initially sedated
with ketamine (20mg/kg intramuscularly), followed
by a combination of halothane (2%), nitrous oxide
(65%), and oxygen (33%) via nose cone. Once a
surgical plane of anesthesia was reached, the animals
were intubated and the halothane concentration was
reduced to 0.75%.
The right femoral artery and vein were isolated by
direct cutdown, and cannulated for blood sampling
and blood pressure monitoring. The right external
jugular vein was cannulated and a pulmonary artery
(PA) thermodilution catheter was inserted and ad-
vanced into the PA for monitoring of central venous
pressure (CVP), PA pressure, cardiac output, core
body temperature, and mixed-venous blood sam-
pling. A pigtail catheter was inserted via the right
external carotid artery into the left ventricle for
colored microsphere injection for measurement of
CBF and renal blood flow (RBF).
The animal was then placed prone on the table in a
head stabilizer, and a 16-mm diameter craniotomywas
created immediately anterior and to the right of the
bregma. AT-shaped bolt was screwed into the craniot-
omy site so it abutted the intact dura. This bolt was
connected to the fluid percussion device, and to a high-
pressure transducer, which permitted quantification
of the force delivered. A second craniotomy was
performed in the left posterior parietal region for
placement of a neonatal intraventricular catheter in
the left lateral ventricle for intracranial pressure (ICP)
monitoring. A third craniotomy was created in the left
anterior skull, 10–12 mm anterior to the ICP site. The
durawas coagulated andaLicoxMCBOxygenMonitor
probe (Integra Life Sciences, Plainsboro, NJ) was
inserted obliquely through the cerebral cortex to rest
in the gray matter of the left parietal cortex. A Licox
temperature probe was also inserted through the sec-
ond craniotomy site. Through a fourth craniotomy just
anterior to the inion, a 20-gauge catheter was placed in
the sagittal sinus for cerebral venous blood sampling.
All craniotomy sites were sealed with dental cement
(Figure 1).
Study Protocol. Cocaine was administered via the
intravenous (IV) route, because this yields the most
reproducible results and is the route of choice in the
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majority of basic science trials.36–39 A dose of 4 mg/kg
was given 10 minutes prior to injury, followed by a
second dose of 2 mg/kg 1 minute prior to injury. We
selected these doses based on extensive review of the
literature. These doses are high enough to demon-
strate clear physiologic effects, with appropriately
elevated serum cocaine levels, but not large enough
to lead to mortality in the absence of TBI.38,40,41
Halothane was used as the primary anesthetic
agent because it has fewer effects on systemic and
cerebral hemodynamics when compared with barbi-
turate or other IV anesthetics.40,41 It is also less likely
to cause apnea, and easy to titrate to level of sedation.
The concentration of halothane required to maintain
anesthesia is reduced when it is delivered with
nitrous oxide, as described in the experimental pro-
tocol. Ketamine, with its relatively short half-life and
rapid redistribution, was used for initial sedation of
the animals, and is preferred over other longer-lasting
agents, such as benzodiazepines. Previous modeling
with sham animals subjected only to instrumentation
was used to control for the confounding effects of
anesthesia.
Cocaine Administration. Cocaine-treated animals
(n = 7) received the first dose 10minutes prior to injury,
and a second dose 1 minute prior to injury (Figure 2).
Cocaine hydrochloride, obtained from the National
Institute on Drug Abuse, was diluted to a total volume
of 20 mL with normal saline and administered to the
right femoral vein over 1 minute. Control animals
(n = 7) received 20 mL of normal saline.
Measurements. Pre-injury baseline metabolic, hemo-
dynamic, and blood flow measurements were ob-
tained, and then repeated 10 minutes after the first
cocaine dose. Traumatic brain injury was inflicted
1minute following the second dose of cocaine or saline
control bolus using a standard fluid percussion device
(t = 0) (Stevenson Machine Company, Cincinnati, OH)
with a target injury of 3 atm.20Tidal volume, respiratory
rate, minute ventilation, and end-tidal carbon dioxide
(ETCO2) level were continuously monitored (Datex
Capnomac Ultima, Datex Instrumentarium Corp.,
Helsinki, Finland). Figure 2 has the complete timeline.
In the event of apnea, oxygen saturation less than 96%,
or minute ventilation less than 2.5 L/min, the animals
wereprovidedventilatory support via a volume-cycled
ventilator (Metomatic VeterinaryVentilator, OhioMed-
ical Products/BOC,MurrayHill,NJ). Tidal volumeand
respiratory rate were adjusted to maintain arterial
partial pressure of carbon dioxide (pCO2) of 40–45
torr. Animals were observed for a total of three hours
following injury. At three hours, the animals were
euthanized with a lethal overdose of pentobarbital.
Heart rate, MAP, CVP, PA pressure, left ventricular
pressure, ICP, respiratory rate, ETCO2, minute ventila-
tion, halothane, oxygen, nitrous oxide inspiratory
concentrations, and core body and brain temperatures
were continuously monitored. Cardiac output was
measured via thermodilution technique at baseline
and every 15minutes until 90minutes following injury,
and then every 30 minutes thereafter. Blood was
collected at baseline, at 15-minute intervals until 90
minutes post-injury, and then at 30-minute intervals
thereafter for hemoglobin, hematocrit, arterial, mixed-
venous, and cerebral venous blood gas measurements,
and arterial and cerebral venous glucose and lactate
measurements (Radiometer Medical: ABL 505, EML
100, and OSM3, Copenhagen, Denmark).
Cerebral blood flow measurements were obtained
using the dye-labeled microsphere technique at base-
line and at 15, 60, and 120 minutes following injury
(detailed in prior studies).19,22,23,42,43 Cerebral per-
fusion pressure, cerebral oxygen delivery (CDO2),
CO2ER, and cerebral metabolic rate of oxygen con-
sumption (CMRO2) were calculated from the mea-
sured variables.22 Blood for serum cocaine and
benzoylecgonine measurements were collected at
time t = 0 and t = 10. Seven milliliters of whole blood
was collected in sodium fluoride- and oxalic acid-
pretreated tubes to prevent cocaine hydrolysis by
Figure 1. Diagram of pig cranium and brain instrumentation
sites. FP = fluid percussion; ICP = intracranial pressure.
Figure 2. Experimental timeline. Coc1 = first dose cocaine (4 mg/kg IV); Coc2 = second dose cocaine (2 mg/kg IV); TBI = traumatic
brain injury; CBF = cerebral blood flow.
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nonspecific plasma cholinesterases, then centrifuged.
The serum was adjusted to a pH of 5.5 with 10% acetic
acid and the samples were then immediately frozen
to 270C. Drug levels were calculated by gas chro-
matography/mass spectrometry (GC/MS; National
Medical Services, Inc., Willow Grove, PA).
Data Analysis. We performed a pre-hoc sample-size
calculation with primary outcomes of CBF, CPP, and
CO2ER at 60 minutes post-injury. Assuming an alpha
(a) value of 0.05, experimental groups of 10 animals
would yield a power of 0.89 for CBF [effect size
(E) = 30 mL/100 g/min, standard deviation (s) = 20],
a power of 0.80 for CPP (E = 20 mm Hg, s = 15), and
a power of 0.80 for CO2ER (E = 0.20, s = 0.15). Inde-
pendent Student’s t-test was used to determine the
differences between the cocaine-administered and con-
trol animals at preselected time points. Repeated-
measures analysis of variance (rmANOVA) was used
for analysis of longitudinally measured parameters.
p-values and 95% confidence intervals (95% CIs) are
reported. Statistical analysis was completed using
Systat version 10.2 (Systat Software, Inc., Point Rich-
mond, CA).
RESULTS
Data are presented as mean (6SD). All animals
survived the 180-minute observation period. Mean
cocaine levels were 1,771 (6403) ng/mL at the time of
injury (t = 0) and 983 (6365) ng/mL at 10 minutes
following injury (t = 10). The mean injury for all
animals was 3.02 (60.30) atm. There was no statisti-
cally significant difference between the two groups in
any of the primary outcome measures: CPP, CBF, or
CO2ER. Although initial plans were for ten animals
per group, after seven per group were completed,
there was clearly no difference between groups, and
the remaining animals were not sacrificed. Results are
summarized in Table 1.
There was a trend toward lower ICP in cocaine-
intoxicated animals, mean = 11.1 (65.8) mm Hg vs.
controls mean = 15.4 (68.2) mm Hg at 60 minutes
post-injury, although this did not reach statistical
significance (p = 0.18; rmANOVA) (Figure 3). The




(n=7) 95% CI p value
ICP (mm Hg) 11.1 (5.8) 15.4 (8.2) 212.5, 3.9 0.18
CPP (mm Hg) 75.1 (15.9) 67.7 (14.2) 210.1, 25.0 0.38
CBF(mL/
100g/min) 59.6 (29.2) 53.1 (16.6) 221.2, 34.1 0.84
RBF(mL/
100g/min) 292.3 (35.3) 247.8 (34.8) 3.7, 85.3 0.59
CMRO2(mL/
100g/min) 356.1 (141.7) 315.4 (103) 2103.5, 185 0.55
CO2ER 0.45 (0.18) 0.43 (0.14) 20.17, 0.2 0.99
CVL (mEq/L) 0.91 (0.19) 1.14 (0.22) 20.47, 0.01 0.06
Cocaine
(ng/mL) 1771 (403)
All data are mean values, with standard deviations in paren-
theses; reported values are at t=60 minutes, except cocaine
(t=1). p-values reported are from rmANOVA comparisons
between groups.
CI = confidence interval; ICP = intracranial pressure; CPP =
cerebral perfusion pressure; CBF = cerebral blood flow; RBF =
renal blood flow; CMRO2 = cerebral metabolic rate of oxygen
consumption; CO2ER = cerebral oxygen extraction ratio;
CVL = cerebral venous lactate.
Figure 3. Intracranial pressure (ICP). ¤, Cocaine; n, Control.
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MAPs did not differ between groups, and the trend
toward lower ICP in the cocaine-administered group
did not translate into improved CPP (Figure 4).
Cardiac outputs were not significantly different
between groups, mean = 2.23 (60.47) L/min in co-
caine-administered animals vs. 2.69 (60.76) L/min in
control animals (p = 0.12; rmANOVA). There was a
trend toward lower cerebral venous lactate (CVL)
levels in the cocaine-intoxicated group, mean = 0.91
(60.19) mEq/L at t = 60, vs. the control group,
mean = 1.14 (60.22) mEq/L. This did not reach sta-
tistical significance, however (p = 0.06; rmANOVA)
(Figure 5). The CBFs decreased significantly from
baseline following injury in both groups, but were
not significantly different between groups (Figure 6).
In contrast to the CBF, the RBF did not decrease
following injury (Figure 7). Although it was signifi-
cantly higher in the cocaine-intoxicated animals,
Figure 5. Cerebral venous lactate (CVL). ¤, Cocaine; n, Control.
Figure 4. Cerebral perfusion pressure (CPP). ¤, Cocaine; n, Control.
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mean = 292.3 (635.3) mL/100 g/min, vs. the control
animals, mean = 247.8 (634.8) mL/100 g/min, at
t = 60 (p = 0.035), this was not reflected in compar-
isons at other time points (p = 0.59; rmANOVA). The
CO2ERs did not differ between the cocaine-intoxi-
cated animals, mean = 0.45 (60.18), and the control
animals, mean = 0.43 (60.14), at t = 60 or other time
points compared (p = 0.99; rmANOVA). There was no
significant difference in the CMRO2 values between
the cocaine-intoxicated group, mean = 356.1 (6141.7)
mL/100 g/min, and the control group, mean = 315.4
(6103) mL/100 g/min (p = 0.55).
DISCUSSION
There have been very few studies investigating the
effects of cocaine in TBI and, to the best of our knowl-
edge, none in large animal models. This investigation
sought to delineate the effects of the drug on basic
physiologic andmetabolic parameters in the setting of a
significant injury. Overall, there was no difference in
the primary outcomes of CPP, CBF, or CO2ER. The CBF
was compromised in both groups following injury, but
there was no difference between groups. The RBF,
which serves as a second physiologic comparison with
CBF, was not significantly affected by brain injury in
either group. It was thought that the trend toward
lower ICP in the cocaine-intoxicated group was not
clinically significant without a difference in any of the
primary outcomes.
The cocaine dosing regimen was chosen after
reviewing basic science data from prior cocaine phar-
macokinetic studies in rats, dogs, and swine, and
discussion with toxicologists who have done basic
science research in the field.36–39,44,45 This protocol
sought to simulate the clinical scenario where a user
might sustain a TBI in a motor vehicle collision while
acutely intoxicated with cocaine. A dose of cocaine
was chosen that would be intoxicating yet would not
result in primary toxicity (cardiac arrhythmias, sei-
zures, cardiovascular collapse) independent of TBI.
Two doses in rapid succession were used to avoid
primary toxicity with a single large dose, and with the
expectation that serum cocaine levels would drop off
rapidly as the drug was metabolized.44,45 IV admin-
istration rather than intraperitoneal administration
was selected with aims of more reliable absorption
and more predictable serum levels.
There was a trend toward lower ICPs in the
cocaine-intoxicated animals; the difference was more
pronounced immediately after injury and became less
significant further out from injury. This blunted rise in
ICP was most pronounced during the time of highest
serum cocaine levels. It is possible that administration
of cocaine is producing effects similar to those of
lidocaine, another local anesthetic that has a similar
biochemical structure (cocaine is an aminoester, while
lidocaine is an aminoamide).46 Lidocaine is a com-
monly used adjunct to intubation in the setting of TBI
and has been shown to blunt increases in ICP in this
setting.47 Lidocaine has also been shown to decrease
CMRO2 in certain dog models, although we did not
observe an effect with cocaine in our model.48,49 The
etiology of cocaine’s effect on ICP is not clear, but
possible hypotheses include blockage of sodium
channels or an effect on the neurotransmitter level,
related to reuptake inhibition of dopamine, serotonin,
or norepinephrine. Although it is possible that in-
creased cerebral vasoconstriction due to elevated
norepinephrine or dopamine may decrease CBF, and
subsequently lower ICP, this was not demonstrated in
this model.
The CVL was also lower in the cocaine-treated
animals, although this did not reach statistical signif-
icance. In past models, elevated levels of CVL have
been shown to be surrogate markers for more severe
injuries, most notably in the setting of concurrent
ethanol intoxication and hemorrhagic shock.19,22 As
an isolated marker of brain injury severity, lower CVL
levels are not enough to infer a neuroprotective effect
from cocaine, especially in the absence of any sig-
nificant differences in CBF or CO2ER. Also, the
differences between very low CVL levels (well less
Figure 6. Global cerebral blood flow (CBF). , Cocaine;
, Control.
Figure 7. Renal blood flow (RBF). , Cocaine; , Control.
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than 2.0 mEq/L) are unlikely to have any clinical
significance.
Although there were trends toward lower ICP and
CVL in the cocaine-treated animals, there was no
difference in the primary outcomes of CPP, CBF,
and CO2ER. Therefore, in this model, cocaine intox-
ication did not have a deleterious or beneficial effect
on TBI.
The relevance of this basic science study lies with
the frequency of TBI as a presentation to most EDs. A
good understanding of the pathophysiology of brain
injury is needed to properly stabilize these patients,
and this is difficult to study in the clinical setting. A
significant subset of TBI patients will have concurrent
intoxication, which can affect their physiologic and
metabolic responses to medical and surgical interven-
tions. Cocaine intoxication is not an infrequent finding
in this group of patients, and may predispose them
to unintentional trauma such as TBI. Although this
investigation did not demonstrate a significant differ-
ence in any of the primary outcome measures, it
represents the beginning of an attempt to investigate
and better understand the complexities of cocaine
intoxication and TBI. Given the trend toward lower
ICP in intoxicated animals, it is possible that a ben-
eficial effect would have been demonstrated with a
lower cocaine dose or an examination of different
outcome measures (neurologic function). Future en-
deavors may include altering the cocaine dose ad-
ministered, incorporating chronic cocaine exposure to
the model, and performing neurologic functional
testing and survival studies. These outcomes may be
more directly relevant to the human experience of
cocaine and TBI, and may help someday to direct
treatment both in the ED and later in the recovery and
rehabilitation phases of injury.
LIMITATIONS
There are a number of limitations to this model
and investigation. This was a model of acute cocaine
toxicity, and cocaine also has chronic deleterious
effects on cardiovascular and cerebrovascular anat-
omy and physiology. In the clinical setting, acute
intoxication with a history of chronic use would be a
more common presentation than acute intoxication
without prior use.
Additionally, IV administration of cocaine may not
replicate precisely intoxication by intranasal or inhala-
tional routes used more commonly in humans. Intra-
venous administration leads to rapid and reproducible
serum levels, but there is potential for differences in
injured brain response in the setting of different routes
of administration. Specifically, one might hypothesize
to see slower onset of effect butmoreprolonged toxicity
from an intranasal or inhalational exposure.
This model is also limited by the duration of obser-
vation. The animals were observed for three hours
and there was no assessment of neurologic function.
Hence, this study cannot rule out the possibility of
differences in long-term neurologic outcome or mor-
bidity, or even longer-term mortality.
Although the study was conclusively negative for
the primary endpoints, there was a trend toward lower
ICP in the cocaine-intoxicated animals. The study was
underpowered to demonstrate such an effect, and a
larger study may have demonstrated a statistically sig-
nificant difference.
Finally, there is potential for a neuroprotective effect
from the anesthesia. Although halothane has the po-
tential to increase ICP by causing cerebral vasodila-
tion, it was selected specifically because it is believed
to have less of a protective effect when compared with
isoflurane or barbiturate anesthesia.50–52
CONCLUSIONS
To the best of our knowledge, this is the first study of
the effects of acute cocaine intoxication in a large
animal model of fluid percussion TBI. In this model,
acute cocaine intoxication did not have any deleteri-
ous effects on the measured physiologic parameters.
Further investigation is needed in this area to better
understand the complex interactions of cocaine with
the injured brain.
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